Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Rawat Prashant B. 2. Date of Event Requiring Statement (Month/Day/Year) 05/07/2026 3. Issuer Name and Ticker or Trading Symbol Mobia Medical, Inc. [MOBI] (Last) (First) (Middle) 2802 FLINTROCK TRACE, SUITE 226 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Operating Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) AUSTIN, TX 78738 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	(1)	12/14/2032	Common Stock	197,243	$3.38	D
Stock Options	(2)	03/26/2035	Common Stock	66,176	$3.73	D
Stock Options	(3)	03/26/2035	Common Stock	60,649	$3.73	D
Stock Options	(4)	10/16/2035	Common Stock	57,084	$3.94	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Rawat Prashant B. 2802 FLINTROCK TRACE, SUITE 226 AUSTIN, TX 78738			Chief Operating Officer

Signatures

/s/ Chase Leavitt, Attorney-in-Fact		05/07/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The stock option vested as to 25% of the underlying shares on June 27, 2023, and will vest thereafter in 36 substantially equal monthly installments
(2)	The stock option vested as to 25% of the underlying shares on October 11, 2025, and will vest thereafter in 36 substantially equal monthly installments.
(3)	The stock option vested as to 25% of the underlying shares on March 5, 2026, and will vest thereafter in 36 substantially equal monthly installments.
(4)	The stock option will vest as to 25% of the underlying shares on October 17, 2026, and will vest thereafter in 36 substantially equal monthly installments.
Remarks: Exhibit 24 - Power of Attorney.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.